Cohu Reports Third Quarter 2026 Results

Cohu reported fiscal Q3 2026 net sales of $173.0 million and GAAP income of $12.1 million, or $0.22 per share. For the first nine months of 2026, net sales were $447.1 million and the GAAP loss was $0.1 million, or $0.00 per share. The release excerpt also reports Q3 non-GAAP income of $23.3 million, but the per-share figure is cut off.

Analysis

The key signal is whether the quarter marks a durable recovery in test-and-handler demand or merely a return to profitability from a weak base. A single profitable quarter does not establish a multi-quarter earnings inflection; the nine-month result leaves limited evidence of sustained conversion so far. For Cohu, the second-order driver is likely customer utilization and test intensity: stronger utilization can lift equipment demand, while pauses in customer spending can quickly defer orders. That makes bookings, backlog, order cancellations, and cash conversion more useful confirmation points than one quarter’s EPS. The release excerpt is incomplete, and provides no year-over-year comparison, outlook, or order data; it is therefore insufficient to establish surprise versus expectations or infer valuation. Near term, a positive price reaction could run ahead of the evidence. Over 1–3 months, guidance and order trends should determine whether the recovery is broadening. Over 6–18 months, sustained investment in semiconductor test capacity would support the structural case, but a cyclical spending pause would reverse it. The contrarian risk is treating quarterly profitability as proof of a durable upcycle before demand indicators confirm it.

Key Decisions for Investors

• No standalone directional trade on this excerpt. Before acting, verify the complete release: revenue and EPS comparisons, guidance, bookings/backlog, cash flow, and management commentary on customer demand.
• Watch COHU for a long setup only if subsequent results show improving orders or backlog alongside continued profitability; absent confirmation, avoid extrapolating one profitable quarter into a recovery thesis.
• If the stock gaps materially higher without stronger forward indicators, consider fading the initial enthusiasm rather than shorting solely on the reported nine-month result. Falsify that cautious stance if guidance and order trends strengthen.
• Track semiconductor test-equipment peers and customer spending commentary for evidence the demand improvement is sector-wide rather than company-specific; do not infer a peer read-through from this truncated release alone.